Tuesday, 8 December 2020

Oxford/AstraZeneca Covid vaccine has 70% efficacy, full trial data shows

Newly published data shows 90% efficacy only in small group who got half-dose first * Coronavirus – latest updates * See all our coronavirus coverage The Oxford/AstraZeneca Covid vaccine has efficacy of 90% in a small group who got a half-dose first, but only 62% in the majority, full trial data newly published in the Lancet has confirmed. The results may create a quandary for regulatory bodies, which will have to decide on how the vaccine should be used if they approve it. Continue reading...
http://dlvr.it/RnFGw0

No comments:

Post a Comment

Chuka

By  Chimamanda Ngozi Adichie ,  Fiction , THE NEW YORKER  February 10, 2025 Photograph by Nakeya Brown for The New Yorker I have always long...